EBS
Price
$8.21
Change
-$0.19 (-2.26%)
Updated
Aug 29, 03:55 PM (EDT)
Capitalization
447.62M
68 days until earnings call
TKNO
Price
$4.33
Change
+$0.02 (+0.46%)
Updated
Aug 29, 04:14 PM (EDT)
Capitalization
230.65M
68 days until earnings call
Interact to see
Advertisement

EBS vs TKNO

Header iconEBS vs TKNO Comparison
Open Charts EBS vs TKNOBanner chart's image
Emergent Biosolutions
Price$8.21
Change-$0.19 (-2.26%)
Volume$200
Capitalization447.62M
Alpha Teknova
Price$4.33
Change+$0.02 (+0.46%)
Volume$100
Capitalization230.65M
EBS vs TKNO Comparison Chart in %
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. TKNO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a StrongBuy and TKNO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (EBS: $8.39 vs. TKNO: $4.31)
Brand notoriety: EBS and TKNO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EBS: 88% vs. TKNO: 88%
Market capitalization -- EBS: $447.62M vs. TKNO: $230.65M
EBS [@Pharmaceuticals: Generic] is valued at $447.62M. TKNO’s [@Pharmaceuticals: Generic] market capitalization is $230.65M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 0 FA rating(s) are green whileTKNO’s FA Score has 0 green FA rating(s).

  • EBS’s FA Score: 0 green, 5 red.
  • TKNO’s FA Score: 0 green, 5 red.
According to our system of comparison, EBS is a better buy in the long-term than TKNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 5 TA indicator(s) are bullish while TKNO’s TA Score has 3 bullish TA indicator(s).

  • EBS’s TA Score: 5 bullish, 5 bearish.
  • TKNO’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both EBS and TKNO are a good buy in the short-term.

Price Growth

EBS (@Pharmaceuticals: Generic) experienced а -9.98% price change this week, while TKNO (@Pharmaceuticals: Generic) price change was -3.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.17%. For the same industry, the average monthly price growth was +68.10%, and the average quarterly price growth was +81.88%.

Reported Earning Dates

EBS is expected to report earnings on Nov 05, 2025.

TKNO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.17% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EBS($448M) has a higher market cap than TKNO($231M). EBS YTD gains are higher at: -12.238 vs. TKNO (-48.383). EBS has higher annual earnings (EBITDA): 344M vs. TKNO (-14.44M). EBS has more cash in the bank: 267M vs. TKNO (24M). TKNO has less debt than EBS: TKNO (29M) vs EBS (668M). EBS has higher revenues than TKNO: EBS (812M) vs TKNO (38.9M).
EBSTKNOEBS / TKNO
Capitalization448M231M194%
EBITDA344M-14.44M-2,382%
Gain YTD-12.238-48.38325%
P/E Ratio3.20N/A-
Revenue812M38.9M2,087%
Total Cash267M24M1,113%
Total Debt668M29M2,303%
FUNDAMENTALS RATINGS
EBS: Fundamental Ratings
EBS
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EBSTKNO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNKEY20.630.02
+0.10%
Danske Bank A/S
NSLYF17.95N/A
N/A
Nestle Malaysia BHD
NIJPF6.78N/A
N/A
Nippon Paper Industries Co Ltd.
CBSTF0.15N/A
-2.33%
THE CANNABIST COMPANY HOLDINGS INC.
INXSF0.25-0.03
-11.15%
Intouch Insight Ltd.

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with SIGA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then SIGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
-2.33%
SIGA - EBS
47%
Loosely correlated
-0.48%
VTRS - EBS
39%
Loosely correlated
-0.10%
ELAN - EBS
35%
Loosely correlated
-0.22%
PAHC - EBS
33%
Poorly correlated
+19.44%
ZOMDF - EBS
29%
Poorly correlated
+0.24%
More

TKNO and

Correlation & Price change

A.I.dvisor tells us that TKNO and OGI have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKNO and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKNO
1D Price
Change %
TKNO100%
-3.15%
OGI - TKNO
32%
Poorly correlated
+3.59%
HROW - TKNO
32%
Poorly correlated
+0.52%
AMRX - TKNO
29%
Poorly correlated
+2.03%
VTRS - TKNO
28%
Poorly correlated
-0.10%
EBS - TKNO
28%
Poorly correlated
-2.33%
More